世界の分子ポイントオブケア(mPOC)デバイス市場2020-2024

◆英語タイトル:Global Molecular Point of Care (mPOC) Devices Market 2020-2024
◆商品コード:IRTNTR43290
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年4月28日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは分子ポイントオブケア(mPOC)デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(感染症、腫瘍、その他)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・分子ポイントオブケア(mPOC)デバイスの世界市場:用途別(感染症、腫瘍、その他)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Molecular Point of Care (mPOC) Devices Market 2020-2024

Technavio has been monitoring the molecular point of care (mPOC) devices market and it is poised to grow by $ 816.62 million during 2020-2024 progressing at a CAGR of 15% during the forecast period. Our reports on molecular point of care (mPOC) devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic and infectious diseases and the increasing number of M&A activities.

The molecular point of care (mPOC) devices market analysis includes application segment and geographic landscapes
Technavio’s molecular point of care (mPOC) devices market is segmented as below
By Application
• Infectious diseases
• oncology
• others

By Geographic Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the rising number of product launches as one of the prime reasons driving the molecular point of care (mPOC) devices market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our molecular point of care (mPOC) devices market covers the following areas:
• Molecular point of care (mPOC) devices market sizing
• Molecular point of care (mPOC) devices market forecast
• Molecular point of care (mPOC) devices market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading molecular point of care (mPOC) devices market vendors that include Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Credo Biomedical Pte. Ltd., Danaher Corp., F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., Oxford Nanopore Technologies Ltd., QIAGEN N.V., and QuantuMDx Group Ltd. Also, the molecular point of care (mPOC) devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-molecular-point-of-care-mpoc-devices-market-2020-2024-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019-2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Infectious diseases – Market size and forecast 2019-2024
o Oncology – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by Application
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume driver – Demand led growth
o Volume driver – Supply led growth
o Volume driver – External factors
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o bioMérieux SA
o Bio-Rad Laboratories Inc.
o Credo Biomedical Pte. Ltd.
o Danaher Corp.
o F. Hoffmann-La Roche Ltd.
o Meridian Bioscience Inc.
o Oxford Nanopore Technologies Ltd.
o QIAGEN N.V.
o QuantuMDx Group Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Application – Market share 2019-2024 (%)
• 22: Comparison by Application
• 23: Infectious diseases – Market size and forecast 2019-2024 ($ million)
• 24: Infectious diseases – Year-over-year growth 2019-2024 (%)
• 25: Oncology – Market size and forecast 2019-2024 ($ million)
• 26: Oncology – Year-over-year growth 2019-2024 (%)
• 27: Others – Market size and forecast 2019-2024 ($ million)
• 28: Others – Year-over-year growth 2019-2024 (%)
• 29: Market opportunity by Application
• 30: Customer landscape
• 31: Market share by geography 2019-2024 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2019-2024 ($ million)
• 34: North America – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ million)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: Asia – Market size and forecast 2019-2024 ($ million)
• 38: Asia – Year-over-year growth 2019-2024 (%)
• 39: ROW – Market size and forecast 2019-2024 ($ million)
• 40: ROW – Year-over-year growth 2019-2024 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Abbott Laboratories – Overview
• 50: Abbott Laboratories – Business segments
• 51: Abbott Laboratories – Key offerings
• 52: Abbott Laboratories – Key customers
• 53: Abbott Laboratories – Segment focus
• 54: bioMérieux SA – Overview
• 55: bioMérieux SA – Business segments
• 56: bioMérieux SA – Key offerings
• 57: bioMérieux SA – Key customers
• 58: bioMérieux SA – Segment focus
• 59: Bio-Rad Laboratories Inc. – Overview
• 60: Bio-Rad Laboratories Inc. – Business segments
• 61: Bio-Rad Laboratories Inc. – Key offerings
• 62: Bio-Rad Laboratories Inc. – Key customers
• 63: Bio-Rad Laboratories Inc. – Segment focus
• 64: Credo Biomedical Pte. Ltd. – Overview
• 65: Credo Biomedical Pte. Ltd. – Product and service
• 66: Credo Biomedical Pte. Ltd. – Key offerings
• 67: Credo Biomedical Pte. Ltd. – Key customers
• 68: Credo Biomedical Pte. Ltd. – Segment focus
• 69: Danaher Corp. – Overview
• 70: Danaher Corp. – Business segments
• 71: Danaher Corp. – Key offerings
• 72: Danaher Corp. – Key customers
• 73: Danaher Corp. – Segment focus
• 74: F. Hoffmann-La Roche Ltd. – Overview
• 75: F. Hoffmann-La Roche Ltd. – Business segments
• 76: F. Hoffmann-La Roche Ltd. – Key offerings
• 77: F. Hoffmann-La Roche Ltd. – Key customers
• 78: F. Hoffmann-La Roche Ltd. – Segment focus
• 79: Meridian Bioscience Inc. – Overview
• 80: Meridian Bioscience Inc. – Business segments
• 81: Meridian Bioscience Inc. – Key offerings
• 82: Meridian Bioscience Inc. – Key customers
• 83: Meridian Bioscience Inc. – Segment focus
• 84: Oxford Nanopore Technologies Ltd. – Overview
• 85: Oxford Nanopore Technologies Ltd. – Product and service
• 86: Oxford Nanopore Technologies Ltd. – Key offerings
• 87: Oxford Nanopore Technologies Ltd. – Key customers
• 88: Oxford Nanopore Technologies Ltd. – Segment focus
• 89: QIAGEN N.V. – Overview
• 90: QIAGEN N.V. – Business segments
• 91: QIAGEN N.V. – Key offerings
• 92: QIAGEN N.V. – Key customers
• 93: QIAGEN N.V. – Segment focus
• 94: QuantuMDx Group Ltd. – Overview
• 95: QuantuMDx Group Ltd. – Product and service
• 96: QuantuMDx Group Ltd. – Key offerings
• 97: QuantuMDx Group Ltd. – Key customers
• 98: QuantuMDx Group Ltd. – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations



【掲載企業】

Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Credo Biomedical Pte. Ltd., Danaher Corp., F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., Oxford Nanopore Technologies Ltd., QIAGEN N.V., and QuantuMDx Group Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の分子ポイントオブケア(mPOC)デバイス市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆